BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company, is focused on utilizing its innovative and proprietary patented drug delivery technologies to develop and commercialize new applications of proven therapeutics. Currently, the company is developing formulations of pharmaceuticals primarily targeted at treatment opportunities in areas such as pain and infections. For further information, visit the Company’s web site at www.biodeliverysciences.com.
- 18 years ago
QualityStocks
BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Hallmark Venture Group, Inc. (OTC: HLLK) Completes Drone Technology Acquisition, Transitions to Operating Business
Hallmark Venture Group (OTC: HLLK) announced the completion of a strategic transaction that transforms the company from…
-
QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on DNA Repair Cancer Therapies
This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced…
-
QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Releases RoadSight UGV Demonstration Video
Safe Pro Group (NASDAQ: SPAI), has released a demonstration video highlighting its new RoadSight capability,…